Tag Archives: CAL

Top 10 Medical Stocks To Invest In 2019

February 14, 2018: Here are four stocks trading with heavy volume among 81 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by more than 2 to 1 and on the Nasdaq, advancers led decliners by about 11 to 4.

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) dropped more than 61% Wednesday to post a new 52-week low of $2.10 after closing at $5.43 on Tuesday. The stock’s 52-week high is $6.97. Volume was around 15 million, more than 30 times the daily average of about 480,000. The company reported failing results on a phase 3 clinical trial.

Neovasc Inc. (NASDAQ: NVCN) fell about 21% Wednesday to post a new 52-week low of $0.26 after closing at $0.33 on Tuesday. The 52-week high is $2.12. Volume of about 7.3 million was around 7 times the daily average. The medical device maker had no specific news.

Tanger Factory Outlet Centers Inc. (NYSE: SKT) traded down nearly 10% Wednesday and posted a new 52-week low of $21.14 after closing Tuesday at $23.47. The stock’s 52-week high is $34.76. Volume was around 6.9 million, nearly five times the daily average. The companr reported results after markets closed Tuesday.

Top 10 Medical Stocks To Invest In 2019: Continental Resources, Inc.(CLR)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Oil prices are higher today than they were just a couple of years ago, after starting to rebound in early 2016. So it isn’t as easy to find the kinds of deals Franco-Nevada was inking not too long ago. But Franco-Nevada still sees value in the energy space — if the right deal is available. For example, it just partnered up with Continental Resources, Inc. (NYSE:CLR).

  • [By Shane Hupp]

    Clearwater Seafoods (TSE:CLR) declared a quarterly dividend on Tuesday, May 8th, Zacks reports. Shareholders of record on Saturday, May 19th will be given a dividend of 0.05 per share on Friday, June 1st. This represents a $0.20 dividend on an annualized basis and a yield of 3.96%. The ex-dividend date of this dividend is Thursday, May 17th.

  • [By Dan Caplinger]

    What could become a key to Franco-Nevada’s turnaround is a recent deal with Continental Resources (NYSE:CLR). Under the strategic relationship, Franco-Nevada will pay $220 million to obtain existing mineral rights that Continental controls. Moreover, the streaming and royalty company will commit as much as $100 million a year for three years to acquire new mineral rights. That led Franco-Nevada to upgrade its long-term oil and gas outlook as well, with the potential to get as much as $120 million to $140 million in revenue by 2022. If achieved, that could begin to make oil and gas almost equally important for Franco-Nevada as precious metals.

  • [By Jason Hall]

    Since oil prices peaked in 2014, both Total and Shell have managed to generate positive total returns for investors who held through the downturn, in large part because of their diverse operations. Neither has come close to outperforming the S&P 500, but it could have been far worse; one only has to look at some of the biggest independent oil producers, including Apache Corporation (NYSE:APA) (down 53%), Anadarko Petroleum Corporation (NYSE:APC) (down 33%), and Continental Resources, Inc. (NYSE:CLR) (down 12.3%) to appreciate the benefit of Total’s and Shell’s more diversified operations. 

Top 10 Medical Stocks To Invest In 2019: Celanese Corporation(CE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Stephens Inc. AR lowered its holdings in shares of Celanese Co. (NYSE:CE) by 9.7% in the 2nd quarter, Holdings Channel reports. The fund owned 4,113 shares of the basic materials company’s stock after selling 441 shares during the period. Stephens Inc. AR’s holdings in Celanese were worth $457,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Jennison Associates LLC trimmed its stake in shares of Celanese Co. (NYSE:CE) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 527,082 shares of the basic materials company’s stock after selling 3,006 shares during the period. Jennison Associates LLC’s holdings in Celanese were worth $58,538,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Wellington Shields Capital Management LLC decreased its stake in shares of Celanese Co. (NYSE:CE) by 9.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,250 shares of the basic materials company’s stock after selling 550 shares during the quarter. Wellington Shields Capital Management LLC’s holdings in Celanese were worth $472,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Invest In 2019: Coca-Cola Enterprises, Inc.(CCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aristotle Capital Management LLC raised its holdings in shares of Coca-Cola European Partners PLC (NYSE:CCE) by 9.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 363,371 shares of the company’s stock after purchasing an additional 30,783 shares during the period. Aristotle Capital Management LLC owned approximately 0.08% of Coca-Cola European Partners worth $15,138,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Coca-Cola European Partners alerts:

    Coca-Cola European Partners (CCE) Lowered to “Sell” at ValuEngine (americanbankingnews.com) $3.69 Billion in Sales Expected for Coca-Cola European Partners (CCE) This Quarter (americanbankingnews.com) Zacks: Analysts Anticipate Coca-Cola European Partners (CCE) to Post $0.81 EPS (americanbankingnews.com) Critical Contrast: Coca-Cola European Partners (CCE) and Coca-Cola Bottling Co. Consolidated (COKE) (americanbankingnews.com) Coca-Cola European Partners (CCE) Sees Large Drop in Short Interest (americanbankingnews.com)

    Shares of CCE traded down $0.51 during trading hours on Monday, hitting $37.88. The stock had a trading volume of 705,278 shares, compared to its average volume of 1,496,087. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.03 and a quick ratio of 0.79. The company has a market cap of $18.60 billion, a PE ratio of 15.85, a P/E/G ratio of 1.93 and a beta of 0.76. Coca-Cola European Partners has a 1-year low of $36.17 and a 1-year high of $44.75.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Coca-Cola European Partners (CCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Coca-Cola European Partners PLC (NYSE:CCE) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 31,000 shares of the company’s stock, valued at approximately $1,260,000.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Coca-Cola European Partners (CCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: New York Times Company (NYT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on New York Times Co Class A (NYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Natalie Walters]

    The New York Times (NYSE:NYT) made a point of alerting investors in its latest earnings call that it would be shifting its attention to some big TV and film projects this year. 

  • [By Logan Wallace]

    New York Times Co (NYSE:NYT) declared a quarterly dividend on Friday, September 21st, RTT News reports. Investors of record on Wednesday, October 3rd will be paid a dividend of 0.04 per share on Thursday, October 18th. This represents a $0.16 annualized dividend and a yield of 0.69%. The ex-dividend date is Tuesday, October 2nd.

  • [By Daniel Sparks]

    Following a surge in the The New York Times’ (NYSE:NYT) stock since the “Trump-bump” effect and an impressive first quarter earlier this year, the newspaper failed to impress last week when it reported its second-quarter results. Suppressed advertising revenue and slowing growth in digital subscribers were reminders of some of the risks to owning shares of the evolving company.

  • [By ]

    On Oct 16, 2008, Warren Buffett wrote a New York Times (NYSE: NYT) op-ed titled “Buy American. I Am.” As markets continued to tumble, critics lambasted the billionaire. I think the Oracle of Omaha has been vindicated.

Top 10 Medical Stocks To Invest In 2019: Snap Inc. (SNAP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market didn’t see much in the way of sustained movement Wednesday, with the major market indexes finished mixed, but close to where they began the day. Various cross-currents pushed shares higher and lower throughout the day, including the potential for a breakthrough on the trade front, and nervousness about the directions of interest rates and monetary policy both in the U.S. and internationally. Weighing on sentiment was bad news from some key individual companies that sent their respective stocks lower. Snap (NYSE:SNAP), Fitbit (NYSE:FIT), and ASML Holding (NASDAQ:ASML) were among the worst performers on the day. Below, we’ll look more closely at these companies to tell you why their shares fared so poorly.

  • [By Paul Ausick]

    And the rest
    Rounding out the top 10 were Bank of America Corp. (NYSE: BAC), J.C. Penney Co. Inc. (NYSE: JCP), Alibaba Group Holding Ltd. (NYSE: BABA),  Snap Inc. (NYSE: SNAP).

  • [By Garrett Baldwin]

    Money Morning Special Situations Strategist Tim Melvin unveiled his powerful secret to becoming the only undefeated trader that we know of on Wall Street. He has 119 stock picking wins… and zero… that’s right, ZERO… losses. And his first recommendation to Money Morning readers is already shooting higher. Find out how you too can become undefeated… right here.

    Four Stocks to Watch Today: UL, SSNLF, TSLA, SNAP
    Snap Inc. (NYSE: SNAP) is absolutely certain that it will become profitable in 2019. Despite the stock falling more than 45% this year and it now where close to its IPO, a company memo was leaked from a top executive that they have a goal of profitability for the full year of 2019. And it seems that a few investors are willing to believe them as shares are up 3.2% this morning. Keep in mind that this memo was leaked after the stock took a 5% hit on Thursday. Today, conglomerate Unilever NV (NYSE: UL) announced that it has abandoned a plan to move its operating headquarters out of the United Kingdom to the Netherlands. The move was originally announced ahead of the Brexit, which continues to barrel forward with tremendous uncertainty for politicians, citizens, and UK-based companies. The firm’s stock was off nearly 1% after it announced that a “significant group of shareholders” did not support the relocation plan. Shares of Tesla Inc. (NASDAQ: TSLA) fell 4.4% after CEO Elon Musk made a rather reckless accusation at the U.S. Securities and Exchange Commission. Musk referred to the SEC as the “Shortseller Enrichment Commission.” His mocking comes just days after Musk settled fraud charges stemming back to his claims in August that he had failed to inform the agency about material company events and misled investors that he had secured funding to take Tesla private. As part of the settlement, Musk also agreed to step down from his role of chair for at least three years and to have his Twitter messages vetted by company officials to

  • [By Garrett Baldwin]

    President Trump will announce today if he will pull the United States out of the Obama-era nuclear deal. Trump wants European members of the treaty to amend certain issues regarding Iran’s uranium enrichment capacity. Energy stocks and oil prices had been rising on speculation that Trump would slap Iran again with economic sanctions, disrupting the region’s oil production. Comcast Corp. (Nasdaq: CMCSA) is currently working to obtain enough capital to purchase certain assets of Twenty-First Century Fox Inc. (NYSE: FOXA). The ability to raise capital would allow Comcast to replace Disney’s $52 billion bid for the many of Fox’s key businesses. Markets are reacting to a speech made this morning by U.S. Federal Reserve Chair Jerome Powell. During a speech in Zurich, Switzerland, Powell said that rising U.S. interest rates would not have a significant impact on emerging markets and foreign stock markets. This has long been a concern for other nations as the U.S. dollar rises and American bonds become more attractive to international investors.
    Four Stocks to Watch Today: DIS, C, SNAP
    The Walt Disney Co. (NYSE: DIS) will lead another busy day of earnings reports today. Investors will be exploring the impact of recent price hikes at the company’s theme parks, as well as the ongoing concerns about cable cutting and how this trend affects ESPN. Markets anticipate that the company will report earnings per share of $1.68 on top of $14.23 billion in revenue. Shares of Citigroup Inc. (NYSE: C) are on the move. The uptick came after activist investor ValueAct announced a $1.2 billion stake in the investment bank. Citigroup shares were up 1.2% in pre-market hours. Shares of Snap Inc. (NYSE: SNAP) gained 1% in pre-market hours. The owner of social media giant Snapchat said that its CFO Drew Vollero will step down next week. The executive will be replaced by a financial executive at Amazon.com Inc. (Nasdaq: AMZN). Snap continues to face incredible pressures after the f

  • [By Evan Niu, CFA]

    In Snap’s (NYSE:SNAP) short life thus far as a public company, it has already suffered from numerous high-profile departures. Snap’s head of human resources, vice president of security, and general counsel left the company last summer, just a few months after the IPO. Engineering chief Tim Sehn quit back in November, and was followed by VP of product Tom Conrad shortly thereafter.

  • [By Chris Lange]

    Snap Inc. (NYSE: SNAP) saw its short interest increase to 123.20 million, compared to the previous level of 108.80 million. Shares were trading at $13.70 in a 52-week range of $10.50 to $21.22.

Top 10 Medical Stocks To Invest In 2019: Pampa Energia S.A.(PAM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Numis Securities restated their add rating on shares of Premier Asset Management Group (LON:PAM) in a report released on Tuesday.

    Separately, Liberum Capital reiterated a buy rating on shares of Premier Asset Management Group in a report on Wednesday, May 23rd.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Pampa Energia (PAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Equities researchers at HSBC began coverage on shares of Pampa Energia (NYSE:PAM) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The firm set a “buy” rating and a $40.00 price target on the utilities provider’s stock. HSBC’s price target would indicate a potential upside of 31.41% from the stock’s current price.

  • [By Joseph Griffin]

    Pampa Energia (NYSE:PAM) and Avangrid (NYSE:AGR) are both utilities companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Top 10 Medical Stocks To Invest In 2019: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts:

    Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

  • [By Joseph Griffin]

    Liberty Mutual Group Asset Management Inc. lowered its stake in shares of Knowles (NYSE:KN) by 22.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,610 shares of the communications equipment provider’s stock after selling 5,088 shares during the period. Liberty Mutual Group Asset Management Inc.’s holdings in Knowles were worth $222,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Knowles Corp (NYSE:KN) insider Michael S. Polacek bought 926 shares of the company’s stock in a transaction on Monday, March 4th. The shares were bought at an average price of $16.28 per share, for a total transaction of $15,075.28. Following the transaction, the insider now owns 84,305 shares of the company’s stock, valued at $1,372,485.40. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top 10 Medical Stocks To Invest In 2019: CompX International Inc.(CIX)

Advisors’ Opinion:

  • [By Shane Hupp]

    CI Financial (TSE:CIX) will issue its quarterly earnings data before the market opens on Thursday, May 10th. Analysts expect the company to announce earnings of C$0.63 per share for the quarter.

  • [By Ethan Ryder]

    CI Financial Corp (TSE:CIX)’s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$23.92 and last traded at C$23.92, with a volume of 138823 shares traded. The stock had previously closed at C$24.14.

  • [By Joseph Griffin]

    Shares of CI Financial Corp (TSE:CIX) have been given an average recommendation of “Hold” by the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and three have given a hold recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is C$25.75.

  • [By Joseph Griffin]

    CI Financial (TSE:CIX) had its price objective decreased by analysts at TD Securities from C$25.00 to C$24.00 in a research note issued to investors on Friday. TD Securities’ price target would indicate a potential upside of 12.36% from the stock’s previous close.

  • [By Shane Hupp]

    CI Financial (TSE:CIX) had its price objective decreased by analysts at TD Securities from C$25.00 to C$24.00 in a research note issued to investors on Friday. TD Securities’ price target would indicate a potential upside of 12.36% from the stock’s previous close.

Top 10 Medical Stocks To Invest In 2019: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Caledonia Mining Co. Plc (TSE:CAL) Director John Mark Learmonth acquired 2,300 shares of Caledonia Mining stock in a transaction dated Friday, August 10th. The stock was acquired at an average cost of C$6.25 per share, with a total value of C$14,375.00.

  • [By Adam Levine-Weinberg]

    The impending disappearance of Payless ShoeSource from the U.S. retail landscape represents an opportunity for rivals to snap up its customers. The two biggest winners are likely to be DSW (NYSE:DSW) and Caleres (NYSE:CAL).

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caleres (CAL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Caleres (NYSE:CAL) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.40-2.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.48. The company issued revenue guidance of approx $2.80 billion, compared to the consensus revenue estimate of $2.79 billion.

  • [By Joseph Griffin]

    Arizona State Retirement System increased its stake in shares of Caleres Inc (NYSE:CAL) by 6.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 66,526 shares of the textile maker’s stock after acquiring an additional 3,877 shares during the period. Arizona State Retirement System owned approximately 0.16% of Caleres worth $1,851,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In 2019: Diodes Incorporated(DIOD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Diodes Incorporated (NASDAQ:DIOD) VP Francis Tang sold 8,600 shares of the company’s stock in a transaction dated Wednesday, May 16th. The stock was sold at an average price of $33.41, for a total value of $287,326.00. Following the completion of the transaction, the vice president now directly owns 86,279 shares of the company’s stock, valued at approximately $2,882,581.39. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Money Morning Staff Reports]

    That’s a great way to cash in on the growth of technology without buying into overhyped (and overpriced) semiconductor stocks, like Diodes Inc. (Nasdaq: DIOD), which trades for 111 times earnings.

  • [By Max Byerly]

    Diodes Incorporated (NASDAQ:DIOD) CFO Richard Dallas White sold 13,000 shares of Diodes stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $37.88, for a total value of $492,440.00. Following the completion of the transaction, the chief financial officer now owns 111,920 shares of the company’s stock, valued at $4,239,529.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Best Biotech Stocks For 2019

What happened

Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) gained a healthy 10.7% last month, according to data from S&P Global Market Intelligence. The spark?

Investors bid up this early commercial-stage biotech stock last month in anticipation of the late-stage results for the company’s advanced kidney cancer drug tivozanib. But the company also announced in late September that it would be presenting at two investor conferences in early October, which seems to have benefited AVEO’s share price last month as well. 

Image Source: Getty Images.

So what

Tivozanib’s late-stage trial, dubbed Tivo-3, could allow the drug to gain entry into the U.S. market. While the drug’s commercial opportunity isn’t entirely clear due to the crowded nature of the kidney cancer market, a U.S. approval would undoubtedly be a major win for AVEO and its shareholders. 

Best Biotech Stocks For 2019: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Max Byerly]

    IndexIQ Advisors LLC lifted its stake in shares of Caleres Inc (NYSE:CAL) by 9.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,101 shares of the textile maker’s stock after acquiring an additional 5,633 shares during the quarter. IndexIQ Advisors LLC’s holdings in Caleres were worth $2,239,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Shares of Caleres Inc (NYSE:CAL) traded down 8% during trading on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $36.61 and last traded at $37.15. 1,252,197 shares traded hands during trading, an increase of 232% from the average session volume of 377,650 shares. The stock had previously closed at $40.36.

  • [By Joseph Griffin]

    Caleres (NYSE:CAL) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.40-2.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.48. The company issued revenue guidance of approx $2.80 billion, compared to the consensus revenue estimate of $2.79 billion.

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Three Stocks to Watch Today: WDAY, AMZN, NKE
    Workday Inc. (Nasdaq: WDAY) leads a busy day of earnings reports Tuesday. The firm will present its quarterly report after the bell. Wall Street expects that the company will report earnings per share of $0.26 on top of $633.1 million in revenue. Amazon.com Inc. (Nasdaq: AMZN) will be generating a lot of buzz today. The e-commerce giant apparently has its eyes on the $88 billion online advertising industry. The firm plans to take direct aim at rivals Alphabet Inc. (Nasdaq: GOOGL) and Facebook Inc. (Nasdaq: FB). Amazon is very close to becoming the second company to surpass the $1 trillion threshold for market capitalization. Nike Inc. (NYSE: NKE) is making headlines the week before the NFL’s opening week starts. The sports apparel giant announced that former San Francisco quarterback Colin Kaepernick will be one of the faces of its 30th anniversary commemorations for its “Just Do It” campaign. Kaepernick has been one of the NFL’s most polarizing figures after he began kneeling during the national anthem to protest police abuse against African Americans and other social injustices. Look for earnings reports from Restoration Hardware Holdings Inc. (NYSE: RH), Casey’s General Stores Inc. (Nasdaq: CASY), Conns Inc. (Nasdaq: CONN), Caleres Inc. (NYSE: CAL), HealthEquity Inc. (NYSE: HQY), and Coupa Software Inc. (Nasdaq: COUP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caleres (CAL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Biotech Stocks For 2019: Standex International Corporation(SXI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Barclays PLC boosted its holdings in Standex Int’l Corp. (NYSE:SXI) by 13.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,804 shares of the industrial products company’s stock after buying an additional 561 shares during the period. Barclays PLC’s holdings in Standex Int’l were worth $459,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Standex Int’l Corp. (NYSE:SXI) has been assigned a consensus rating of “Hold” from the eight brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $120.50.

  • [By Ethan Ryder]

    Standex Int’l Corp. (NYSE:SXI) – Equities researchers at William Blair boosted their Q3 2019 earnings per share (EPS) estimates for shares of Standex Int’l in a note issued to investors on Monday, October 1st. William Blair analyst N. Heymann now expects that the industrial products company will earn $1.51 per share for the quarter, up from their prior estimate of $1.49.

  • [By Stephan Byrd]

    Synex International (TSE:SXI) Director Glenn Stanley Mcdonnell sold 250,000 shares of the stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of C$0.50, for a total transaction of C$125,000.00.

Best Biotech Stocks For 2019: M/A-COM Technology Solutions Holdings, Inc.(MTSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) have earned a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $31.15.

  • [By Steve Symington]

    Shares of MACOM Technology Solutions Holdings Inc. (NASDAQ:MTSI) fell 11.8% on Wednesday after Stifel analyst Tore Svanberg downgraded his rating on the semiconductor device and component specialist.

  • [By Ethan Ryder]

    MACOM Technology Solutions (NASDAQ:MTSI) had its target price raised by equities researchers at Stifel Nicolaus from $18.00 to $22.00 in a research report issued to clients and investors on Thursday. The firm currently has a “hold” rating on the semiconductor company’s stock. Stifel Nicolaus’ target price would suggest a potential downside of 7.95% from the stock’s previous close.

  • [By Logan Wallace]

    Shares of MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) were down 5.6% on Wednesday . The company traded as low as $23.84 and last traded at $24.15. Approximately 1,031,600 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 1,262,816 shares. The stock had previously closed at $25.58.

  • [By Logan Wallace]

    US Bancorp DE increased its holdings in shares of MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) by 116.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,658 shares of the semiconductor company’s stock after buying an additional 7,339 shares during the period. US Bancorp DE’s holdings in MACOM Technology Solutions were worth $227,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Best Heal Care Stocks To Buy Right Now

&l;img class=&q;size-large wp-image-225 &q; src=&q;http://blogs-images.forbes.com/teresaghilarducci/files/2018/05/man-1200×1280.jpg?width=960&q; alt=&q;&q; data-height=&q;1280&q; data-width=&q;1200&q;&g;

Something&a;rsquo;s gotta give. 10,000 people are turning 65 every day for the next few decades and a little more than half &l;a href=&q;http://www.economicpolicyresearch.org/resource-library/downward-mobility-in-retirement&q; target=&q;_blank&q;&g;can&a;rsquo;t afford&l;/a&g; to retire. Most of them retire anyway.

One solution: work longer and get more money! Paul Davidson of &l;em&g;USA Today&l;/em&g; &l;a href=&q;https://www.usatoday.com/story/money/2018/05/21/retirement-delayed-firms-keep-older-workers-hire-retirees/613722002/&q; target=&q;_blank&q;&g;detailed&l;/a&g; cheerful profiles of older people who fired themselves from retirement and came back to work, commanding their employers to adjust their work schedules. I don&a;rsquo;t blame Paul for the hopeful solution to the retirement crisis, but the numbers don&a;rsquo;t support the hope. In the same week as Paul&a;rsquo;s article, Actuary Elizabeth Bauer, a fellow Forbes contributor, &l;a href=&q;https://www.forbes.com/sites/ebauer/2018/05/24/too-old-to-work-too-young-to-retire-everyone-just-works-longer-isnt-an-easy-fix/#55e73ea72d05&q;&g;cautioned&l;/a&g; many may not be healthy enough to work longer.

Best Heal Care Stocks To Buy Right Now: (SMPQY)

Advisors’ Opinion:

  • [By ]

    I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ

Best Undervalued Stocks To Invest In 2019

A quick note: With the 280+ comments I received on my piece published over the weekend about selling a portion of your Apple (NASDAQ:AAPL) stock, I wanted to further clarify my position as the context is important in reading this piece. Unfortunately, many I fear read the title and glossed over the article before commenting, albeit insightful and informative commentary.

My main thesis was: generate a handsome profit by selling a portion (1% up to whatever you are comfortable with) of your current Apple position, because with the current Q1 numbers and future uncertainty in the hardware world, there are more undervalued stocks out there to “seek alpha.”

Unfortunately the title, “Consider Selling a Portion of Your Apple Stock to Capture Gains and Reinvest in Undervalued Sectors for Higher Probability of Alpha” – was not fit to print. And because I’m all about equal opportunity, I’ve written a strategy to make money off naysayers like me! Now onto your regularly scheduled programming

Best Undervalued Stocks To Invest In 2019: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Reuters]

    Wendy Maeda/The Boston Globe via Getty Images
    NEW YORK — Walgreen is moving 120,000 employees to a private health insurance exchange from coverage provided directly from carriers, the company will announce Wednesday.
    The pharmacy chain will join 17 other large employers on the Aon Hewitt Corporate Health Exchange as part of a growing movement to offer employees fixed dollar amounts to purchase their own plans on such exchanges.
    The end-cost to employees depends on the plan chosen, but they typically get more options than under traditional arrangements. Private exchanges mimic the coverage mandated as part of the Affordable Care Act. Enrollment in the public exchanges starts Oct. 1.
    “What happens to employer contributions over time? Will they put in as much as they put in the past? These are unanswered questions but potential negatives,” says Paul Fronstin, a senior research associate with the Employee Benefit Research Institute. The benefit to Walgreen and other employers is unknown at this point, as their cost-savings aren’t clear.
    Of the 180,000 Walgreen (WAG) employees eligible for health care insurance, 120,000 opted for coverage for themselves and 40,000 family members. Another 60,000 employees, many of them working part-time, weren’t eligible for health insurance.
    Aon Hewitt (AON) says other participants in its program include retailer Sears Holding (SHLD) and Darden Restaurants (DRI). These new additions raise enrollment to 330,000 from 100,000 last year, and Aon Hewitt estimates enrollment will jump to 600,000 next year, a fivefold increase from 2012.
    By 2017, nearly 20 percent of employees nationwide could get their health insurance through a private exchange, according to Accenture Research (ACN). A recent report by the National Business Group on Health said that 30 percent of large employers are considering moving active employees to exchanges by 2015.

    Other major providers of private exchanges include Mercer, a division of Marsh & Mc

Best Undervalued Stocks To Invest In 2019: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Best Undervalued Stocks To Invest In 2019: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION NOTICE: “Brian S. Dexheimer Sells 500 Shares of Plantronics (PLT) Stock” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at www.tickerreport.com/banking-finance/3355123/brian-s-dexheimer-sells-500-shares-of-plantronics-plt-stock.html.

Best Undervalued Stocks To Invest In 2019: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Shares of Caleres Inc (NYSE: CAL) got a boost, shooting up 12 percent to $31.99 after the company posted upbeat Q3 earnings.

    QAD Inc. (NASDAQ: QADA) shares were also up, gaining 14 percent to $29.44 after the company posted strong Q3 results.

Best Undervalued Stocks To Invest In 2019: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

Top Performing Stocks To Invest In Right Now

The Q3 2016 earnings report for Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) is scheduled for before the market opens onThursday (November 9th), but theIsrael connection along with changing consumer tastes havehad shares going from fizzy to flat. However, Sodastream International is making efforts to revamp its image with shares surging after the last earnings report.

A technical chart for Sodastream International shows shares peaking in August and falling back a bit with conflicting trend lines:

A long term performance chart shows Sodastream International underperforming, but doing better this yearwhile the outperformance of large cap Monster Beverage Corp (NASDAQ: MNST) may have stalled and small cap Primo Water Corporation (NASDAQ: PRMW)has been in a strong uptrend for two years:

Top Performing Stocks To Invest In Right Now: The Swatch Group AG (SWGAY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Shares of Swiss watchmaker Swatch Group AG (SWGAY) tumbled 4% mid-afternoon Wednesday as it became apparent the company could lose out to a well-received Apple Inc. (AAPL) Apple Watch 3 released Tuesday.

  • [By SEEKINGALPHA.COM]

    That’s good news to the luxury goods sector – from Swiss watches to high fashion and expensive cognac – for which Chinese consumers make up around 30 percent of all global sales. In a note to investors, analysts at investment firm Exane BNP Paribas expects growth to continue to trend upwards during 2017, with Swatch Group (OTCPK:SWGAY), Richemont SA (OTCPK:CFRHF), and Burberry (OTCPK:BURBY) the companies most likely to gain.

Top Performing Stocks To Invest In Right Now: ZTE Corporation (ZTCOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The United States has a history of preventing Chinese companies that are even suspected of being state-owned from selling certain products into key industries. Huawei and ZTE (OTCPK:ZTCOF), for example, were under harsh scrutiny for their telecommunications equipment.

  • [By SEEKINGALPHA.COM]

    Chinese telco equipment giant ZTE (OTCPK:ZTCOF) has been actively cooperating and communicating with relevant U.S. government departments in order to reach a conclusion of the investigation related to the compny’s violations of sanctions on Iran.

Top Performing Stocks To Invest In Right Now: Data I/O Corporation(DAIO)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 2.51 percent. Meanwhile, top losers in the sector included Autodesk, Inc. (NASDAQ: ADSK), down 15 percent, and Data I/O Corporation (NASDAQ: DAIO) down 13 percent.

Top Performing Stocks To Invest In Right Now: Goldfield Corporation (The)(GV)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested buying small cap electrical infrastructure stockGoldfield Corp (NYSEMKT:GV):

Top Performing Stocks To Invest In Right Now: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Shares of Caleres Inc (NYSE: CAL) got a boost, shooting up 12 percent to $31.99 after the company posted upbeat Q3 earnings.

    QAD Inc. (NASDAQ: QADA) shares were also up, gaining 14 percent to $29.44 after the company posted strong Q3 results.